HPV Vaccination

This is a series of screening tests for chromosomal anomalies that can be performed from as early as the 10th week of pregnancy until delivery. In this test, the genetic DNA material from the pregnancy and the fetus, which circulates in the mother's blood, is examined in a laboratory using a blood sample taken from the mother. It is particularly useful for screening for trisomy 21 (Down syndrome), trisomy 13 and 18, as well as sex chromosome anomalies. Since there is no intervention in the pregnancy, it does not harm the fetus. Although the screening test largely indicates the risk of chromosomal anomalies, it is not a definitive diagnostic test.